Echo Therapeutics (ECTE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Sales | -44 | 159 | 230 | 104 | 47 |
| Gross Profit | -44 | 159 | 230 | 104 | 47 |
| Operating Expenses | 2,222 | 1,974 | 1,785 | 817 | 956 |
| Operating Income | -2,267 | -1,816 | -1,555 | -713 | -909 |
| Interest Expense | 0 | 1 | 13 | 33 | 3 |
| Other Income | 894 | -123 | -3,029 | 363 | 329 |
| Pre-tax Income | -1,373 | -1,940 | -4,597 | -383 | -583 |
| Net Income Continuous | -1,373 | -1,940 | -4,597 | -383 | -583 |
| Net Income | $-1,373 | $-1,940 | $-4,597 | $-1,147 | $-583 |
| EPS Basic Total Ops | -0.40 | -0.60 | -2.00 | -0.40 | -0.20 |
| EPS Basic Continuous Ops | -0.40 | -0.57 | -1.41 | -0.11 | -0.20 |
| EPS Diluted Total Ops | -0.40 | -0.60 | -2.00 | -0.40 | -0.20 |
| EPS Diluted Continuous Ops | -0.40 | -0.57 | -1.41 | -0.11 | -0.20 |
| EBITDA(a) | $-2,251 | $-1,806 | $-1,550 | $-707 | $-879 |